Pricing

Log inSign up

Bryologyx

20 people · 0 jobs
‌

BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.

Industries

Biotechnology, Commercial

Headquarters

Danville, United States

Employees

1-10

Links

Org chart

Thomas M. Loarie
Co-Founder, CEO & Director
Collapse
Reza Ilkhani
CFO
Bruce Jenett
General Counsel
David Crockford
VP, Clinical Development & Logistics

Board & advisors

John Abeles
Co-Founder & Chairman
Paul Wender
Co-Founder & Director
Nelson L. Levy
Director
Michael Ma
Director
Clint Severson
Director
Omar Duramad
Advisor
Cohava Gelber
Advisor
William Grossman
Advisor
Michael Rossbach
Advisor
Richard L. Schilsky
Advisor
Steven Deeks
Advisor
Paul Volberding
Advisor
Jerry Zack
Advisor
Justin Stebbing
Advisor

Teams

+5

Advisory Team

9 people · 0 jobs

+2

Directors Team

6 people · 0 jobs

+1

Leadership Team

5 people · 0 jobs

Offices

Similar companies

Gilead Sciences

159 followers

Regeneron

130 followers

Illumina

79 followers

Agilent Technologies

81 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

28 followers

Cytiva

16 followers

PerkinElmer

12 followers

Editas Medicine

5 followers

Organogenesis

5 followers

Explore companies